Literature DB >> 6220164

Chromosomal abnormality rates at amniocentesis and in live-born infants.

E B Hook, P K Cross, D M Schreinemachers.   

Abstract

Regression-smoothed maternal age-specific rates of six different categories of cytogenetic abnormalities in recent large-scale prenatal cytogenetic studies were multiplied by independently derived fetal selection coefficients--factors that adjust for the excess likelihood of spontaneous loss of cytogenetically abnormal fetuses--to obtain estimated maternal age-specific rates of these categories of cytogenetic abnormalities in live-born infants. The derived rates apply to women whose only risk factor is advanced maternal age. The categories analyzed were 47,+21 (Down's syndrome), 47,+18 (Edwards' syndrome), 47,+13 (Patau's syndrome), 47,XXY (Klinefelter's syndrome), 47,XXX, and the group of other clinically significant abnormalities considered collectively. The rate of all clinically significant abnormalities considered together derived in this study was about five per 1,000 at age 35 years, 15 per 1,000 at age 40 years, and 50 per 1,000 at age 45 years.

Entities:  

Mesh:

Year:  1983        PMID: 6220164

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  57 in total

1.  An economic model of amniocentesis choice.

Authors:  Eduardo Fajnzylber; V Joseph Hotz; Seth G Sanders
Journal:  Adv Life Course Res       Date:  2010-03-01

2.  Parental age and the origin of trisomy 21. A study of 302 families.

Authors:  F Dagna Bricarelli; M Pierluigi; M Landucci; A Arslanian; D A Coviello; M A Ferro; P Strigini
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

3.  A maternal serum screen for trisomy 18: an extension of maternal serum screening for Down syndrome.

Authors:  A J Staples; E F Robertson; E Ranieri; R G Ryall; E A Haan
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

4.  A test of maternal human chorionic gonadotropin during pregnancy as an adaptive filter of human gestations.

Authors:  Tim A Bruckner; Katherine B Saxton; Michelle Pearl; Robert Currier; Martin Kharrazi
Journal:  Proc Biol Sci       Date:  2012-09-26       Impact factor: 5.349

5.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 6.  An Older Woman in Early Pregnancy: What Antenatal Screening is Appropriate?

Authors:  S Sulaiha Aznal
Journal:  Malays Fam Physician       Date:  2008-12-31

7.  AluI-resistant chromatin of chromosome 18: classification, frequencies and implications.

Authors:  A Babu; R S Verma; S R Patil
Journal:  Chromosoma       Date:  1987       Impact factor: 4.316

8.  Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts.

Authors:  Donald E Kuhn; Gerard J Nuovo; Mickey M Martin; Geraldine E Malana; Adam P Pleister; Jinmai Jiang; Thomas D Schmittgen; Alvin V Terry; Katheleen Gardiner; Elizabeth Head; David S Feldman; Terry S Elton
Journal:  Biochem Biophys Res Commun       Date:  2008-04-01       Impact factor: 3.575

9.  Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study.

Authors:  P W Yoon; S B Freeman; S L Sherman; L F Taft; Y Gu; D Pettay; W D Flanders; M J Khoury; T J Hassold
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

10.  Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.

Authors:  Juliet A Moncaster; Roberto Pineda; Robert D Moir; Suqian Lu; Mark A Burton; Joy G Ghosh; Maria Ericsson; Stephanie J Soscia; Anca Mocofanescu; Rebecca D Folkerth; Richard M Robb; Jer R Kuszak; John I Clark; Rudolph E Tanzi; David G Hunter; Lee E Goldstein
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.